The six-gate roadmap, Strategy Lock through Phase 2 Enablement, shows that the sequencing discipline built for one IND is what determines whether a company’s development engine can repeat for a second and third program.
White Paper
From IND to Phase 2: The 24 Months That Determine Whether Your Development Platform Scales
Related Resources
All Resources
post
The Importance of Stability Studies in CMC Compliance
Read More
post
Understanding the FDA’s Evolving Expectations for Biopharma Compliance
Read More
post
CMC Considerations for Biotech Startups Entering Clinical Trials
Read More
case-study
From Data to Dossier: Smart Scale-Up Solutions in Biopharmaceutical Manufacturing
Read More
Let's move from science to success.
Let’s Talk